ArticleRheumatology (Oxford, England)2017

Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation.

Giulio Cavalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.